Acquisitions7 Jul 2026, 01:40 pm
Jagsonpal Pharma Completes 69.77% Stake Acquisition in Aequitas Healthcare
AI Summary
Jagsonpal Pharmaceuticals Limited has announced the completion of the acquisition of 69.77% of the equity stake in Aequitas Healthcare Private Limited. This transaction, initially proposed for an 85% stake, has now resulted in Aequitas Healthcare becoming a subsidiary of Jagsonpal Pharmaceuticals. The company has informed the stock exchanges of this significant development, marking a strategic move to expand its operations and market presence through this acquisition.
Key Highlights
- Jagsonpal Pharmaceuticals acquired 69.77% stake in Aequitas Healthcare.
- Aequitas Healthcare is now a subsidiary of Jagsonpal Pharmaceuticals.
- The acquisition was part of a larger proposed 85% stake purchase.
- This marks a significant strategic expansion for the company.
Price Impact
More from JAGSNPHARM